{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T06:53:01Z","timestamp":1775631181281,"version":"3.50.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Non-Hodgkin Lymphoma (NHL) is the most prevalent hematological malignancy worldwide, making its mortality trends a critical public health concern. This study examines temporal trends in NHL-related mortality in the United States from 1999 to 2020, with a focus on sex-based, racial, and regional disparities.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Data were obtained from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database. Crude and age-adjusted mortality rates (AAMR) were analyzed and annual percentage changes (APCs) were calculated using Joinpoint regression to identify temporal trends.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among 560,469 NHL-related deaths, AAMR declined from 12.86 (1999) to 8.26 per 100,000 (2020), with an increasing trend from 2018 to 2020 (APC: 0.89 [95% CI, \u22120.55 to 1.64]). Males consistently exhibited higher mortality rates compared to females (12.62 vs. 7.58), and NH White Americans exhibited the highest mortality among racial groups (10.34). Regional disparities were evident, with the Midwestern region recording the highest AAMR (10.64), and Minnesota, Nebraska, Iowa, Ohio and Vermont exhibiting the highest state-specific rates. Nonmetropolitan areas exhibited higher mortality rates than metropolitan areas (10.28 vs 9.62).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>While NHL-related mortality in the U.S. has declined overall, recent upward trends from 2018 to 2020, particularly among certain demographic and geographic subgroups, raise concerns. These findings highlight the need for further investigation into underlying factors and targeted interventions to address disparities and improve NHL outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0327809","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T17:34:37Z","timestamp":1758130477000},"page":"e0327809","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends and disparities in Non-Hodgkin Lymphoma related mortality in the United States, 1999\u20132020"],"prefix":"10.1371","volume":"20","author":[{"given":"Muhammad","family":"Saad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza","family":"Aisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Umer","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3544-3513","authenticated-orcid":true,"given":"Maryam","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9959-007X","authenticated-orcid":true,"given":"Syed Zaeem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab Siddiqua","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad Ahmed","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1054-4291","authenticated-orcid":true,"given":"Haiqa","family":"Aamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Aman","family":"Makda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazza","family":"Aamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Khalid","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2814-7314","authenticated-orcid":true,"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"pone.0327809.ref001","article-title":"Non-Hodgkin lymphoma","volume":"362","author":"A Bowzyk Al-Naeeb","year":"2018","journal-title":"BMJ"},{"key":"pone.0327809.ref002","unstructured":"Key Statistics for Non-Hodgkin Lymphoma. Accessed February 16, 2024. https:\/\/www.cancer.org\/cancer\/types\/non-hodgkin-lymphoma\/about\/key-statistics.html"},{"issue":"3","key":"pone.0327809.ref003","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/02841860500531682","article-title":"Epidemiology and etiology of non-Hodgkin lymphoma--a review","volume":"45","author":"K Ekstr\u00f6m-Smedby","year":"2006","journal-title":"Acta Oncol"},{"key":"pone.0327809.ref004","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"WH Organization","year":"2001"},{"issue":"10","key":"pone.0327809.ref005","first-page":"45","article-title":"Acquired immunodeficiency syndrome-associated lymphomas","author":"CE Freter","year":"1990","journal-title":"J Natl Cancer Inst Monogr"},{"key":"pone.0327809.ref006","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers Related to Immunodeficiencies: Update and Perspectives","volume":"7","author":"E Mortaz","year":"2016","journal-title":"Front Immunol"},{"issue":"5","key":"pone.0327809.ref007","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7326\/0003-4819-105-5-668","article-title":"Non-Hodgkin\u2019s lymphoma after treatment of Hodgkin\u2019s disease: association with Epstein-Barr virus","volume":"105","author":"AF List","year":"1986","journal-title":"Ann Intern Med"},{"issue":"8871","key":"pone.0327809.ref008","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","article-title":"The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori","volume":"342","author":"T Hussell","year":"1993","journal-title":"Lancet"},{"issue":"3","key":"pone.0327809.ref009","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI115078","article-title":"Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia","volume":"87","author":"MR Smith","year":"1991","journal-title":"J Clin Invest"},{"issue":"9119","key":"pone.0327809.ref010","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"JJ Goedert","year":"1998","journal-title":"The Lancet"},{"issue":"5","key":"pone.0327809.ref011","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00001622-200109000-00007","article-title":"Epidemiologic trends in HIV-associated lymphomas","volume":"13","author":"CA Clarke","year":"2001","journal-title":"Current Opinion in Oncology"},{"issue":"15","key":"pone.0327809.ref012","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"FD Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"pone.0327809.ref013","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/10815589241262003","article-title":"Non-Hodgkin lymphoma mortality disparities across different sexes, races, and geographic locations","volume":"72","author":"JY Tan","year":"2024","journal-title":"J Investig Med"},{"key":"pone.0327809.ref014","unstructured":"CDC WONDER. https:\/\/wonder.cdc.gov\/. 2025 March 11."},{"issue":"7624","key":"pone.0327809.ref015","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm E","year":"2007","journal-title":"BMJ"},{"issue":"11","key":"pone.0327809.ref016","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2021.01.032","article-title":"Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018","volume":"77","author":"R Aggarwal","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"pone.0327809.ref017","first-page":"1","article-title":"Introduction","year":"1998","journal-title":"Cardiopulmonary Medicine from Imperial College Press"},{"key":"pone.0327809.ref018","first-page":"100499","article-title":"Underlying and contributing causes of mortality from CDC WONDER-Insights for researchers","volume":"50","author":"AMK Minhas","year":"2025","journal-title":"Am Heart J Plus"},{"issue":"3","key":"pone.0327809.ref019","article-title":"COVID-19 and non-Hodgkin\u2019s lymphoma: A common susceptibility pattern?","volume":"18","author":"DM Sara","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"pone.0327809.ref020","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/ijc.34873","article-title":"Changes in mortality associated with different hematologic malignancies during the pandemic in the United States","volume":"154","author":"U Fedeli","year":"2024","journal-title":"Int J Cancer"},{"key":"pone.0327809.ref021","doi-asserted-by":"crossref","first-page":"942122","DOI":"10.3389\/fonc.2022.942122","article-title":"Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method","volume":"12","author":"S Xie","year":"2022","journal-title":"Front Oncol"},{"issue":"8725","key":"pone.0327809.ref022","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/0140-6736(90)92846-A","article-title":"Race or class versus race and class: mortality differentials in the United States","volume":"336","author":"V Navarro","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"pone.0327809.ref023","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/jayao.2014.0037","article-title":"Survival Differences by Race\/Ethnicity and Neighborhood Socioeconomic Status in Adolescents and Young Adults Diagnosed with Non-Hodgkin Lymphoma","volume":"4","author":"C Chao","year":"2015","journal-title":"J Adolesc Young Adult Oncol"},{"key":"pone.0327809.ref024","doi-asserted-by":"crossref","first-page":"101372","DOI":"10.1016\/j.gore.2024.101372","article-title":"Mitigating disparity?: Treatment patterns, survival, and recurrence rates by race, ethnicity, and hospital site across a large urban health system","volume":"53","author":"K Papatla","year":"2024","journal-title":"Gynecol Oncol Rep"},{"issue":"24","key":"pone.0327809.ref025","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2217\/fon-2020-1262","article-title":"Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials","volume":"17","author":"DR Camidge","year":"2021","journal-title":"Future Oncol"},{"issue":"5","key":"pone.0327809.ref026","first-page":"489","article-title":"Global patterns and trends in the incidence of non-Hodgkin lymphoma","volume":"30","author":"A Miranda-Filho","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"9","key":"pone.0327809.ref027","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/ijc.34163","article-title":"Global patterns of non-Hodgkin lymphoma in 2020","volume":"151","author":"A Mafra","year":"2022","journal-title":"Int J Cancer"},{"issue":"1","key":"pone.0327809.ref028","first-page":"5","article-title":"Epidemiology of Non-Hodgkin\u2019s Lymphoma","volume":"9","author":"KC Thandra","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"pone.0327809.ref029","unstructured":"Who is at risk for HIV?. https:\/\/www.hiv.gov\/hiv-basics\/overview\/about-hiv-and-aids\/who-is-at-risk-for-hiv. 2025 March 11."},{"issue":"1","key":"pone.0327809.ref030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"LM Morton","year":"2006","journal-title":"Blood"},{"issue":"5","key":"pone.0327809.ref031","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2141.2009.08010.x","article-title":"The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research","volume":"148","author":"A Smith","year":"2010","journal-title":"Br J Haematol"},{"key":"pone.0327809.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/205215","article-title":"Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA","volume":"2014","author":"C Sarkozy","year":"2014","journal-title":"Lymphoma"},{"issue":"5","key":"pone.0327809.ref033","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood-2013-07-517037","article-title":"Suboptimal dosing of rituximab in male and female patients with DLBCL","volume":"123","author":"M Pfreundschuh","year":"2014","journal-title":"Blood"},{"issue":"2","key":"pone.0327809.ref034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/bjh.12008","article-title":"Single-agent lenalidomide in relapsed\/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences","volume":"159","author":"HE Eve","year":"2012","journal-title":"Br J Haematol"},{"issue":"12","key":"pone.0327809.ref035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008135","article-title":"Reproductive Factors and Non-Hodgkin Lymphoma Risk in the California Teachers Study","volume":"4","author":"J Prescott","year":"2009","journal-title":"PLoS ONE"},{"issue":"3","key":"pone.0327809.ref036","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/aje\/kwn119","article-title":"Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use","volume":"168","author":"JS Lee","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"4","key":"pone.0327809.ref037","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ijc.25730","article-title":"Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study","volume":"129","author":"Y Lu","year":"2011","journal-title":"Int J Cancer"},{"issue":"2","key":"pone.0327809.ref038","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/joe.0.1720387","article-title":"Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women","volume":"172","author":"D Racho\u0144","year":"2002","journal-title":"J Endocrinol"},{"issue":"3","key":"pone.0327809.ref039","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-127-3-199708010-00002","article-title":"Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma","volume":"127","author":"HA Preti","year":"1997","journal-title":"Ann Intern Med"},{"key":"pone.0327809.ref040","unstructured":"Estrogen receptor profiles in human peripheral blood lymphocytes. https:\/\/pubmed.ncbi.nlm.nih.gov\/20542061\/. 2024 February 12."},{"issue":"7","key":"pone.0327809.ref041","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2011.68","article-title":"Effect of ligand-activated estrogen receptor \u03b2 on lymphoma growth in vitro and in vivo","volume":"25","author":"K Yakimchuk","year":"2011","journal-title":"Leukemia"},{"issue":"11","key":"pone.0327809.ref042","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/cncr.23914","article-title":"Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma","volume":"113","author":"M Wang","year":"2008","journal-title":"Cancer"},{"key":"pone.0327809.ref043","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1186\/1471-2458-14-1278","article-title":"A cross-sectional study of geographic differences in health risk factors among young Australian adults: the role of socioeconomic position","volume":"14","author":"KAE Patterson","year":"2014","journal-title":"BMC Public Health"},{"issue":"23","key":"pone.0327809.ref044","doi-asserted-by":"crossref","first-page":"653","DOI":"10.15585\/mmwr.mm6723a1","article-title":"Obesity Prevalence Among Adults Living in Metropolitan and Nonmetropolitan Counties - United States, 2016","volume":"67","author":"EA Lundeen","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"pone.0327809.ref045","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/00002030-200307040-00013","article-title":"Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma","volume":"17","author":"C Hoffmann","year":"2003","journal-title":"AIDS"},{"issue":"6","key":"pone.0327809.ref046","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3816\/CLML.2010.n.086","article-title":"A decade of progress in lymphoma: advances and continuing challenges","volume":"10","author":"CR Flowers","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"33","key":"pone.0327809.ref047","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1200\/JCO.2005.03.1674","article-title":"New treatment options have changed the survival of patients with follicular lymphoma","volume":"23","author":"RI Fisher","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"pone.0327809.ref048","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1200\/JCO.2005.03.3696","article-title":"Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center","volume":"24","author":"Q Liu","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"pone.0327809.ref049","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"B Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"18","key":"pone.0327809.ref050","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"23","author":"P Feugier","year":"2005","journal-title":"J Clin Oncol"},{"issue":"22","key":"pone.0327809.ref051","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"LH Sehn","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"pone.0327809.ref052","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"M Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"issue":"19","key":"pone.0327809.ref053","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma","volume":"24","author":"TM Habermann","year":"2006","journal-title":"JCO"},{"issue":"1","key":"pone.0327809.ref054","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.med.59.060906.220345","article-title":"A Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin\u2019s Lymphoma","volume":"59","author":"A Molina","year":"2008","journal-title":"Annu Rev Med"},{"issue":"6","key":"pone.0327809.ref055","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1517\/14656560902895715","article-title":"Treatment strategies for relapsed and refractory aggressive non-Hodgkin\u2019s lymphoma","volume":"10","author":"M Prichard","year":"2009","journal-title":"Expert Opin Pharmacother"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0346387","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T17:34:47Z","timestamp":1758130487000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327809"}},"subtitle":[],"editor":[{"given":"Purnima","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0327809","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]}}}